A trial by scientists at the University of Alberta is being proposed for an antiviral drug, a protease inhibitor, that was first developed to treat feline coronavirus. The drug has been found to prevent viral replication in human cells infected with SARS-CoV-2.
Antiviral used to treat cat coronavirus also works against SARS-CoV-2.
Leave a reply